Vertigo affects 1 in 10 people globally and is increasingly common in India, impacting 70 million individuals. Key symptoms ...

Here's who gabapentin was originally approved for, what it's used for today and why it's becoming a drug of increasing ...

The US FDA has approved a new drug, Cobenfy, for treating schizophrenia in adults. This is a first new class for medication ...

Most teens in the chroming videos—31%—used permanent markers to chrome, the study found. Meanwhile, 17% used air dusters, 12% ...

PARSIPPANY, N.J., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of the first and ...